ATE111921T1 - Menschlicher kristallinischer granulocyt- koloniestimulierungsfaktor und dessen herstellung. - Google Patents

Menschlicher kristallinischer granulocyt- koloniestimulierungsfaktor und dessen herstellung.

Info

Publication number
ATE111921T1
ATE111921T1 AT89110022T AT89110022T ATE111921T1 AT E111921 T1 ATE111921 T1 AT E111921T1 AT 89110022 T AT89110022 T AT 89110022T AT 89110022 T AT89110022 T AT 89110022T AT E111921 T1 ATE111921 T1 AT E111921T1
Authority
AT
Austria
Prior art keywords
granulocyte colony
crystalline
production
csf
stimulation factor
Prior art date
Application number
AT89110022T
Other languages
English (en)
Inventor
Sadao Tanaka
Toshio Akimoto
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1-126392A external-priority patent/JP3004655B2/ja
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE111921T1 publication Critical patent/ATE111921T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT89110022T 1988-06-03 1989-06-02 Menschlicher kristallinischer granulocyt- koloniestimulierungsfaktor und dessen herstellung. ATE111921T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13711188 1988-06-03
JP23138888 1988-09-14
JP1-126392A JP3004655B2 (ja) 1988-06-03 1989-05-19 結晶性ヒト顆粒球コロニー刺激因子及びその製造方法

Publications (1)

Publication Number Publication Date
ATE111921T1 true ATE111921T1 (de) 1994-10-15

Family

ID=27315322

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89110022T ATE111921T1 (de) 1988-06-03 1989-06-02 Menschlicher kristallinischer granulocyt- koloniestimulierungsfaktor und dessen herstellung.

Country Status (4)

Country Link
EP (1) EP0344796B1 (de)
AT (1) ATE111921T1 (de)
DE (1) DE68918331T2 (de)
ES (1) ES2063783T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ236819A (en) * 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
EP0955365A3 (de) * 1992-06-09 2000-12-20 Chiron Corporation Kristallisierung von M-CSF
US5581476A (en) * 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
KR100241257B1 (ko) * 1997-05-22 2000-02-01 한승수 인체 과립구 콜로니 자극 인자 활성물질 및 그것의 제조방법
JP2000319298A (ja) * 1999-03-04 2000-11-21 Seibutsu Bunshi Kogaku Kenkyusho:Kk 蛋白質複合体の結晶、構造座標、及び構造座標の使用
US6555660B2 (en) 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
US6831158B2 (en) 2000-01-10 2004-12-14 Maxygen Holdings Ltd. G-CSF conjugates
US6646110B2 (en) 2000-01-10 2003-11-11 Maxygen Holdings Ltd. G-CSF polypeptides and conjugates
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
MXPA04000231A (es) 2001-07-11 2004-05-04 Maxygen Holdings Ltd Conjugados del factor de estimulacion de colonias de granulocitos.
AU2003261723A1 (en) 2002-08-27 2004-03-19 Takeda Chemical Industries, Ltd. Cxcr4 antagonist and use thereof
AU2003262087B2 (en) * 2002-09-11 2010-11-11 Chugai Seiyaku Kabushiki Kaisha Protein purification method
US7785601B2 (en) 2002-12-31 2010-08-31 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
US7695723B2 (en) 2002-12-31 2010-04-13 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
CA2607844C (en) 2005-06-01 2012-07-10 Maxygen Holdings Ltd. Pegylated g-csf polypeptides and methods of producing same
DE102005033250A1 (de) † 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF
EP2094274A4 (de) 2006-12-21 2011-05-11 Biokine Therapeutics Ltd T-140 peptid-analoga mit cxcr4 superagonisten-aktivität für knochenmarkserholung
EP2396023A2 (de) 2009-02-11 2011-12-21 Yeda Research and Development Co. Ltd. Kurze peptide aus beta-defensin
CN102481332A (zh) 2009-06-14 2012-05-30 拜欧肯疗法有限公司 用于提高血小板水平的肽疗法
EP2841084B1 (de) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Cxcr4 antagonist peptid zur verwendung in der behandlung von lungenkrebs
WO2017009842A2 (en) 2015-07-16 2017-01-19 Biokine Therapeutics Ltd. Compositions and methods for treating cancer
ES2830726T3 (es) 2016-02-23 2021-06-04 Biolinerx Ltd Método para seleccionar un régimen de tratamiento para la leucemia mieloide aguda (LMA)

Also Published As

Publication number Publication date
EP0344796B1 (de) 1994-09-21
EP0344796A3 (en) 1990-09-26
DE68918331T2 (de) 1995-05-18
ES2063783T3 (es) 1995-01-16
DE68918331D1 (de) 1994-10-27
EP0344796A2 (de) 1989-12-06

Similar Documents

Publication Publication Date Title
DE68918331D1 (de) Menschlicher kristallinischer Granulocyt-Koloniestimulierungsfaktor und dessen Herstellung.
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
MY102016A (en) Thiazolidinedione derivatives, their production and use.
EG17753A (en) Novel pharmacological compounds
CA2123321A1 (en) Combination chemotherapy
IL75536A (en) Crystalline calcium pseudomonate,its preparation and pharmaceutical and veterinary compositions comprising it
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
DE3681144D1 (de) Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.
EP0152273A3 (en) A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use
HU9200204D0 (en) Process for the production of benzyloxi-phenyl derivatives and medical preparations containing them
HUT58037A (en) Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
EP0253146A3 (de) Die Verwendung von D-fenfluramin zur Herstellung von Arzneimitteln, zur Behandlung von Depressionen
EP0310126A3 (en) Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines
DE69029040D1 (de) Megakaryocytopoietischer faktor
GR3002365T3 (en) Medicines containing as a mixture interferon and 1-desoxy-piperidinoses, process for their manufacture and their use
JPS6438073A (en) Novel derivative of tetrahydropyridine, manufacture and intermediate, use as drug and medicinal composition
EP0359062A3 (de) Antibiotikum GE 2270
EP0240986A3 (en) D-nor-7-ergoline derivatives, process for preparing them, pharmaceutical composition and use
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ZA873431B (en) Derivatives of 4-phenyl-4-oxo-2-butenoic acid,their preparation process,their use as medicaments and the compositions containing them
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
ATE84418T1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
ATE66611T1 (de) Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee